Special Problems in Chemotherapy

  • J. D. Williams
  • A. M. Geddes

Part of the Chemotherapy book series (CT, volume 3)

Table of contents

  1. Front Matter
    Pages i-xiv
  2. D. A. Mitchison
    Pages 17-23
  3. Makoto Hori, Kayoko Suzukake, Yoshimasa Uehara, Hamao Umezawa
    Pages 43-46
  4. R. L. Parsons, G. M. Hossack, P. F. G. Boon, D. M. Burley
    Pages 63-72
  5. Gladys L. Hobby, H. William Harris, Charles Felton, John Edsall
    Pages 73-74
  6. G. Franz, M. Kaether, R. Reimann
    Pages 87-89
  7. P. F. Sparling, F. A. Sarubbi Jr., E. Blackman
    Pages 91-96
  8. King K. Holmes, William O. Harrison, Richard Hooper, E. Russell Alexander
    Pages 103-109
  9. M. R. J. Salton, K. S. Kim, R. Davis, K. Y. Cho
    Pages 111-119
  10. G. W. Csonka, S. H. Qureshi
    Pages 121-123
  11. A. Lassus, O.-V. Renkonen, T. Rostila
    Pages 127-131
  12. A. Hofstetter, H. Blenk, R. Rangoonwala
    Pages 133-136
  13. G. L. Ridgway, V. Little, E. Radwanska, G. I. M. Swyer
    Pages 137-142
  14. P. E. R. Rhemrev, F. Kosasih
    Pages 155-160
  15. J. Erdei, F. Hernádi, Cs. Jászberényi, T. Gunda, G. Szabó
    Pages 199-203
  16. Gerald Wagner, Smith Shadomy
    Pages 211-215
  17. I. Haupt, H. Thrum, E. Schuhmann, R. Geuther
    Pages 217-222
  18. M. T. Perez-Ureña, E. Garcia, M. Espinosa, A. Portoles
    Pages 223-228
  19. A. Portoles, M. Espinosa, E. Garcia, M. T. Perez-Ureña
    Pages 229-234
  20. C. Coutsogeorgopoulos
    Pages 235-239
  21. M. de M. Pinto-Ribeiro
    Pages 241-245
  22. P. Cavanagh, Sandra Kattan, R. B. Sykes
    Pages 247-249
  23. Fumio Matsumoto, Yasushi Ueda, Masahisa Ohmori, Kohya Shiba
    Pages 251-256
  24. J. Andrews, M. J. Bywater, A. M. Emmerson, C. Keane, D. S. Reeves, R. Wise
    Pages 271-277
  25. Jun Okada, Toyoko Oguri, Nozomu Kosakai
    Pages 279-282
  26. O. N. Speranskaya, I. P. Fomina, V. S. Zueva
    Pages 299-305

About this book


The International Society of Chemotherapy meets every two years to review progress in chemotherapy of infections and of malignant disease. Each meeting gets larger to encompass the extension of chemotherapy into new areas. In some instances, expansion has been rapid, for example in cephalosporins, pen­ icillins and combination chemotherapy of cancer - in others slow, as in the field of parasitology. New problems of resistance and untoward effects arise; reduction of host toxicity without loss of antitumour activity by new substances occupies wide attention. The improved results with cancer chemotherapy, es­ pecially in leukaemias, are leading to a greater prevalence of severe infection in patients so treated, pharmacokinetics of drugs in normal and diseased subjects is receiving increasing attention along with related problems of bioavailability and interactions between drugs. Meanwhile the attack on some of the major bacterial infections, such as gonorrhoea and tubercu­ losis, which were among the first infections to feel the impact of chemotherapy, still continue to be major world problems and are now under attack with new agents and new methods. From this wide field and the 1,000 papers read at the Congress we have produced Proceedings which reflect the variety and vigour of research in this important field of medicine. It was not possible to include all of the papers presented at the Congress but we have attempted to include most aspects of cur­ rent progress in chemotherapy.


cancer chemotherapy kinetics pharmacokinetics research resistance toxicity

Editors and affiliations

  • J. D. Williams
    • 1
  • A. M. Geddes
    • 2
  1. 1.The London Hospital Medical CollegeLondonUK
  2. 2.East Birmingham HospitalBirminghamUK

Bibliographic information

Industry Sectors
Chemical Manufacturing
Consumer Packaged Goods